Latest California Healthline Stories
The state’s Department of Public Health said that suspected cases of the fungal infection increased by more than one-third in the first 10 months, compared with the same period in 2016, putting it on pace to break last year’s record high.
Fertility doctors around the country are hosting soirees to pitch to mostly affluent women the benefits of preserving their eggs.
Amid financial losses and the uncertainty of federal funding under Obamacare, health insurers find there’s money to be made in Medicaid.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Joanne Kenen of Politico and Alice Ollstein of Talking Points Memo discuss the first days of open enrollment for 2018 individual health insurance plans and whether the Democratic gains in Tuesday’s off-off-year elections will have any impact on health care policy in Washington, D.C.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
The legalization of recreational marijuana in California and other states poses an added challenge for drug education programs targeting youths.
Feeling fidgety about U.S. PIRG’s latest report? KHN gets experts to weigh in with their thoughts about the findings and consumers’ risks.
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
The two FDA-approved manufacturers of the vaccine, hit by an unexpected spike in demand, have had difficulty keeping pace. In San Diego County, home to the deadliest outbreak in the nation, officials are postponing a campaign to give at-risk residents the second of two doses.
With the nation’s opioid crisis, urine testing has become a booming business and is especially lucrative for doctors who operate their own labs, a Kaiser Health News investigation finds. And dozens of practitioners have earned ‘the lion’s share’ of their Medicare income exclusively from urine drug screens.